TelyRx News Releases

TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare

Tue, 14 Jul 2026 07:00:00 -0400

Expansion follows milestone of one million prescriptions filled Clearwater, Florida--(Newsfile Corp. - July 14, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced a major expansion of its Clearwater headquarters and pharmacy operations, following the milestone of one million prescriptions filled and first-quarter revenue growth of 180% year-over-year. The move more than triples TelyRx's overall...

TelyRx Holdings Inc. Announces DTC Eligibility for U.S. Traded Shares

Fri, 10 Jul 2026 07:00:00 -0400

Clearwater, Florida--(Newsfile Corp. - July 10, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced that its subordinate voting shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company ("DTC"). DTC eligibility is expected to simplify trading, improvement settlement efficiency, and enhance the liquidity and accessibility of TelyRx's...

TelyRx to Present at the Global Technology Virtual Investor Conference July 9, 2026

Wed, 08 Jul 2026 13:05:00 -0400

Clearwater, Florida--(Newsfile Corp. - July 8, 2026) - Hot on the heels of its one million prescriptions filled milestone, TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, announced today that Vanessa Slowey, President and Chief Executive Officer, and John Cascio, Chief Financial Officer, will present live at the Global...

TelyRx Announces Voting Results from Annual General Meeting of Shareholders

Mon, 15 Jun 2026 18:57:00 -0400

Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the "Meeting"), has been elected. In addition, the other resolution put to vote at the Meeting was passed. The detailed results of the...

TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy

Mon, 08 Jun 2026 08:00:00 -0400

Milestone reflects strong customer response to simpler, more convenient access to essential healthcare Clearwater, Florida--(Newsfile Corp. - June 8, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF), a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, today announced it has surpassed one million prescriptions filled nationwide since inception, a major milestone in the company's growth.The milestone...

TelyRx Commences Trading on the OTCQX Market in the United States

Fri, 05 Jun 2026 07:00:00 -0400

Clearwater, Florida--(Newsfile Corp. - June 5, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that its subordinate voting shares will commence trading on the OTCQX Best Market ("OTCQX"), the premier tier of the OTC Markets Group in the United States, under the symbol "TELYF". TelyRx's subordinate voting shares will also continue to trade on the TSX under the...

TelyRx to Present at the Small Cap Growth Virtual Investor Conference June 4, 2026

Wed, 03 Jun 2026 08:35:00 -0400

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Clearwater, Florida--(Newsfile Corp. - June 3, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that Vanessa Slowey, President and Chief Executive Officer, and John Cascio, Chief Financial Officer, will present live at the Small Cap...

TelyRx Announces First Quarter 2026 Financial Results

Tue, 12 May 2026 17:57:00 -0400

Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced financial results for the first quarter ended March 31, 2026. All dollar amounts are expressed in U.S. dollars.Highlights for the First Quarter of 2026Revenue increased to $19.4 million, compared to $14.3 million in Q4 2025 and $6.9 million in Q1 2025Number of Prescriptions Filled...

TelyRx to Host First Quarter 2026 Financial Results Conference Call on Wednesday, May 13, 2026 at 8:30 am ET

Tue, 12 May 2026 10:45:00 -0400

Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its first quarter 2026 financial results on Wednesday, May 13, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its first quarter 2026 financial results for the period ended March 31, 2026, after market close...

TelyRx Announces Year-End 2025 Financial Results

Tue, 21 Apr 2026 16:49:00 -0400

Clearwater, Florida--(Newsfile Corp. - April 21, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today filed audited financial statements for TelyRx, Inc., its wholly-owned subsidiary and reverse takeover acquirer, on SEDAR+ for the year ended December 31, 2025. All dollar amounts are expressed in U.S. dollars.Highlights for the Year and Fourth Quarter of 2025Revenue increased to $42.9...